The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment
Pediatric acute lymphoblastic leukemia (ALL) affects a substantial number of children every year and requires a long and rigorous course of chemotherapy treatments in three stages, with the longest phase, the maintenance phase, lasting 2–3 years. While the primary drugs used in the maintenance phase...
Збережено в:
| Автори: | , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Oxford University Press
2017-04-01
|
| Серія: | Genomics, Proteomics & Bioinformatics |
| Предмети: | |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S1672022917300475 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|